Matches in SemOpenAlex for { <https://semopenalex.org/work/W1511279391> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W1511279391 endingPage "119.8" @default.
- W1511279391 startingPage "119.8" @default.
- W1511279391 abstract "Abstract Toll-like receptors (TLR) are involved in the pathogenesis of numerous autoimmune diseases, including psoriasis. The role of TLR7 and TLR9 in psoriasis is well established and TLR8 may also contribute to this disease. Blocking the activation of these receptors through a TLR antagonist represents a novel approach to the treatment of psoriasis. We have developed IMO-8400, a synthetic DNA compound that inhibits TLR7-, TLR8-, and TLR9-mediated immune responses in cell-based assays. Additionally, following subcutaneous administration in non-human primates, it suppresses ex-vivo immune responses mediated through these receptors. IMO-8400 was evaluated in preclinical mouse models of psoriasis, induced by IL-23 cytokine or antimicrobial peptide LL-37. Psoriasis-like skin lesions were induced in the ear of C57BL/6 mice by intradermal injection of IL-23 or LL37. Injected mice were treated with subcutaneous administration of IMO-8400. Mice were euthanized at end of study and tissue samples were taken for histological examination. Increase in ear thickness was inhibited in a dose-dependent manner by treatment with IMO-8400. Reduction in epidermal hyperplasia and infiltrating leukocytes was observed in sample tissues. Treatment with IMO-8400 was associated with elevation of serum IL-10 levels. IMO-8400 can effectively suppress lesion development in these psoriasis models. IMO-8400 has potential as a novel agent for the treatment of psoriasis and other autoimmune diseases." @default.
- W1511279391 created "2016-06-24" @default.
- W1511279391 creator A5044897744 @default.
- W1511279391 creator A5062802371 @default.
- W1511279391 creator A5069014764 @default.
- W1511279391 creator A5072072657 @default.
- W1511279391 creator A5073741821 @default.
- W1511279391 creator A5088791437 @default.
- W1511279391 date "2012-05-01" @default.
- W1511279391 modified "2023-10-11" @default.
- W1511279391 title "IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis (119.8)" @default.
- W1511279391 doi "https://doi.org/10.4049/jimmunol.188.supp.119.8" @default.
- W1511279391 hasPublicationYear "2012" @default.
- W1511279391 type Work @default.
- W1511279391 sameAs 1511279391 @default.
- W1511279391 citedByCount "6" @default.
- W1511279391 countsByYear W15112793912013 @default.
- W1511279391 countsByYear W15112793912021 @default.
- W1511279391 countsByYear W15112793912022 @default.
- W1511279391 crossrefType "journal-article" @default.
- W1511279391 hasAuthorship W1511279391A5044897744 @default.
- W1511279391 hasAuthorship W1511279391A5062802371 @default.
- W1511279391 hasAuthorship W1511279391A5069014764 @default.
- W1511279391 hasAuthorship W1511279391A5072072657 @default.
- W1511279391 hasAuthorship W1511279391A5073741821 @default.
- W1511279391 hasAuthorship W1511279391A5088791437 @default.
- W1511279391 hasConcept C104317684 @default.
- W1511279391 hasConcept C126322002 @default.
- W1511279391 hasConcept C136449434 @default.
- W1511279391 hasConcept C150194340 @default.
- W1511279391 hasConcept C170493617 @default.
- W1511279391 hasConcept C190727270 @default.
- W1511279391 hasConcept C203014093 @default.
- W1511279391 hasConcept C2776709828 @default.
- W1511279391 hasConcept C2776885963 @default.
- W1511279391 hasConcept C2778122271 @default.
- W1511279391 hasConcept C2779138994 @default.
- W1511279391 hasConcept C2779836521 @default.
- W1511279391 hasConcept C2780564577 @default.
- W1511279391 hasConcept C2780942790 @default.
- W1511279391 hasConcept C55493867 @default.
- W1511279391 hasConcept C71924100 @default.
- W1511279391 hasConcept C86803240 @default.
- W1511279391 hasConcept C8891405 @default.
- W1511279391 hasConcept C98274493 @default.
- W1511279391 hasConceptScore W1511279391C104317684 @default.
- W1511279391 hasConceptScore W1511279391C126322002 @default.
- W1511279391 hasConceptScore W1511279391C136449434 @default.
- W1511279391 hasConceptScore W1511279391C150194340 @default.
- W1511279391 hasConceptScore W1511279391C170493617 @default.
- W1511279391 hasConceptScore W1511279391C190727270 @default.
- W1511279391 hasConceptScore W1511279391C203014093 @default.
- W1511279391 hasConceptScore W1511279391C2776709828 @default.
- W1511279391 hasConceptScore W1511279391C2776885963 @default.
- W1511279391 hasConceptScore W1511279391C2778122271 @default.
- W1511279391 hasConceptScore W1511279391C2779138994 @default.
- W1511279391 hasConceptScore W1511279391C2779836521 @default.
- W1511279391 hasConceptScore W1511279391C2780564577 @default.
- W1511279391 hasConceptScore W1511279391C2780942790 @default.
- W1511279391 hasConceptScore W1511279391C55493867 @default.
- W1511279391 hasConceptScore W1511279391C71924100 @default.
- W1511279391 hasConceptScore W1511279391C86803240 @default.
- W1511279391 hasConceptScore W1511279391C8891405 @default.
- W1511279391 hasConceptScore W1511279391C98274493 @default.
- W1511279391 hasIssue "1_Supplement" @default.
- W1511279391 hasLocation W15112793911 @default.
- W1511279391 hasOpenAccess W1511279391 @default.
- W1511279391 hasPrimaryLocation W15112793911 @default.
- W1511279391 hasRelatedWork W1506194577 @default.
- W1511279391 hasRelatedWork W1511279391 @default.
- W1511279391 hasRelatedWork W2062987859 @default.
- W1511279391 hasRelatedWork W2084889692 @default.
- W1511279391 hasRelatedWork W2095927374 @default.
- W1511279391 hasRelatedWork W2350863451 @default.
- W1511279391 hasRelatedWork W2469906138 @default.
- W1511279391 hasRelatedWork W2789922392 @default.
- W1511279391 hasRelatedWork W3030577180 @default.
- W1511279391 hasRelatedWork W3034007056 @default.
- W1511279391 hasVolume "188" @default.
- W1511279391 isParatext "false" @default.
- W1511279391 isRetracted "false" @default.
- W1511279391 magId "1511279391" @default.
- W1511279391 workType "article" @default.